Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy

Area of Science:

• * Hematopoietic stem cell (HSC) biology and gene therapy.
• * Gene transfer vector development and optimization.
• * Translational research using nonhuman primate models.

Background:

• * Hematopoietic stem cells (HSCs) are ideal for gene therapy due to self-renewal and differentiation.
• * Early human trials showed low gene transfer efficiency into HSCs using retroviral vectors.
• * Quiescent nature of human HSCs and low receptor density limit retroviral vector transduction.

Purpose of the Study:

• * To evaluate and improve gene transfer efficiency into human HSCs.
• * To achieve clinically relevant levels of gene-modified cells for HSC gene therapy.
• * To explore strategies for high-level, long-term transgene expression in HSCs.

Main Methods:

• * Utilization of nonhuman primate models due to biological similarities with humans.
• * Optimization of ex vivo transduction conditions, including Flt-3 ligand and fibronectin fragment (CH-296).
• * Employing specific retroviral vectors (gibbon ape leukemia virus, feline endogenous retrovirus envelopes) and exploring lentiviral vectors.

Main Results:

• * Achieved clinically relevant gene-modified cell levels (around 10% or more) in peripheral blood post-HSC transplantation.
• * Demonstrated successful gene transfer into HSCs using optimized ex vivo culture and vector systems.
• * Identified strategies to enhance gene transfer efficiency in large animal models.

Conclusions:

• * Nonhuman primate models are essential for advancing HSC gene therapy.
• * Optimized ex vivo transduction and vector design significantly improve gene transfer efficiency.
• * Further research in nonhuman primates is needed to ensure high-level, long-term transgene expression for effective therapy.